AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous...

Press/Media: Press / Media

PeriodApr 29 2016

Media coverage

1

Media coverage

  • TitleAbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous...
    Media name/outletPharmacy Choice
    CountryUnited States
    Date4/29/16
    PersonsFred Poordad